AnemoCheck
Whole Blood Hemoglobin Determination. 510(k) K163215, from Sanguina, LLC (Atlanta, GA). Product code KHG, class 2.
As of Nov 20, 2026, K163215 is an FDA 510(k) held by Sanguina, LLC, substantially equivalent on Sep 13, 2017 after 301 days, with no recalls tied to it in FDA's recall database.
- Review time: 301 days
- Recalls: 0
- Cited as a predicate by: 1 device
The AnemoCheck is an in vitro diagnostic semi-quantitative assay for use in point-of-care, clinical and doctor office laboratories for the determination of hemoglobin level and estimation of hematocrit percentage (within normal hemoglobin range) in anticoagulated (K2EDTA, heparin or citrate) whole blood (capillary or venous).
- Hemocue Hemoglobin 201 + System Article 121704K032203 · Hemocue, Inc. · Aug 25, 2003
- Bayer Advia 2120 Hematology Analyzer With Autoslide SystemK042251 · Bayer Healthcare, LLC · Sep 17, 2004
- AnemoCheck HomeK221508 · Sanguina, Inc. · Sep 29, 2023
- AnemoCheck HomeK221508 · Sanguina, Inc. · Sep 29, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 16, 2016
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7500
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files